Routine measurements of factor? VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply

Nogami Keiji

首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >Routine measurements of factor? VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply

【24h】

Routine measurements of factor? VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply

机译：常规测量因素？ viii VIII活性和抑制剂滴度在利用抗独立型单克隆抗体的存在下存在：答复

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thrombosis and haemostasis: JTH》 |2019年第3期|共3页
作者
Nogami Keiji;
展开▼
作者单位

Department of PediatricsNara Medical UniversityKashihara Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Routine measurements of factor? VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply [J] . Nogami Keiji Journal of thrombosis and haemostasis: JTH . 2019,第3期

机译：常规测量因素？ viii VIII活性和抑制剂滴度在利用抗独立型单克隆抗体的存在下存在：答复
2. Routine measurements of factor VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: comment [J] . Wada Hideo, Matsumoto Takeshi, Yamashita Yoshiki, Journal of thrombosis and haemostasis: JTH . 2019,第3期

机译：利用抗独立型单克隆抗体的eMicizumab存在因子VIII VIII活性和抑制剂滴度的常规测量结果：评论
3. Routine measurements of factor VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies [J] . Nogami K., Soeda T., Matsumoto T., Journal of thrombosis and haemostasis: JTH . 2018,第7期

机译：常规测量因子VIII VIII活性和抑制剂滴度在利用抗独立型单克隆抗体存在的emicizumab存在下
4. Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A [C] . V. Aumann, G. Lutze (Jr.), G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人为因子VIII抑制剂的动物因子VIII的乙酰丁酮：先天性血友病药中抑制剂患者的血浆中的预防
5. Characterization of VLDL receptor interactions with plasma proteins lipoprotein(a), apolipoprotein E, tissue factor pathway inhibitor, and factor VIII [D] . Ruiz, Jose Fernando 2004

机译：VLDL受体与血浆蛋白脂蛋白（a），载脂蛋白E，组织因子途径抑制剂和因子VIII相互作用的表征
6. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody both of which inhibit factor VIII procoagulant activity to amino acid residues threonine351-serine365 of the factor VIII heavy chain. [O] . P A Foster, C A Fulcher, R A Houghten, 1988

机译：将均抑制因子VIII促凝活性的鼠单克隆抗因子VIII抗体和人抗因子VIII同种抗体的结合区定位于因子VIII重链的苏氨酸351-丝氨酸365的氨基酸残基。
7. Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies [O] . K. Nogami, T. Soeda, T. Matsumoto, 2018

机译：常规测量因子VIII活性和抑制剂滴度在利用抗独立型单克隆抗体存在的eMicizumab存在下

Routine measurements of factor? VIII VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply

著录项

相似文献

相关主题

期刊订阅